Cogstate is a global leader in cognitive measurement dedicated to enhancing brain health assessment through innovative solutions. The company's mission focuses on optimizing cognitive assessments to aid in the development of new therapeutics and provide valuable insights into brain health for clinical care. Cogstate offers a comprehensive range of products and services, including digital cognitive assessments, endpoint data quality solutions, remote assessment services, and specialized scientific consulting. Their therapeutic expertise spans various conditions such as Alzheimer's disease, dementia, Parkinson's disease, schizophrenia, and more.

With a robust clinical and scientific network, Cogstate collaborates with experts in psychology and neurology to support biopharmaceutical research initiatives worldwide. They are also committed to fostering an inclusive workplace that reflects diversity and promotes acceptance among their workforce. As they continue to advance cognitive measurement and support healthcare initiatives, Cogstate remains at the forefront of enhancing the understanding and treatment of cognitive health.